EntryPoint Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

EntryPoint Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$483K	Buy
2024 Q1	–	Sell
2023 Q4	$49.6K	Buy